pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Sanofi-Aventis US LLC

updated 4mo ago
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval38 co-mentions · 19 sources
  • drugSOLIQUA 100/3324 co-mentions · 12 sources
  • company$SNYSanofi19 co-mentions · 19 sources
  • company$SNYNFSanofi19 co-mentions · 19 sources
  • drugADLYXIN14 co-mentions · 7 sources
  • druginsulin glargine12 co-mentions · 12 sources
  • druginsulin glargine LA12 co-mentions · 12 sources
  • drugToujeo LA12 co-mentions · 12 sources
pipeline
23
marketed
19
phase 3
0
catalysts ytd
6
approvals ytd
5
recalls ytd
0

Pipeline(23)

view full pipeline →
pipeline depth23 products
Marketed: 19Unknown: 4
19Marketed4Unknown
Marketed
(insulin glargine + lixisenatide)
Type 2 Diabetes
Marketed
ADLYXIN
Marketed
Plavix
Acute Coronary Syndrome
Marketed
RIFADIN
Tuberculosis
Marketed
RIFATER
Marketed
Renvela
Hyperphosphatemia In Chronic Kidney Disease
Marketed
Toujeo LA
Type 1 Diabetes (Juvenile Diabetes)
Marketed
alirocumab
Heterozygous Familial Hypercholesterolemia (heFH)
Marketed
cabazitaxel
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Marketed
coagulation factor IX (recombinant), Fc fusion protein LA
Hemophilia B (Factor IX Deficiency)
Marketed
dronedarone hydrochloride
Atrial Fibrillation
Marketed
fexinidazole
African Trypanosomiasis

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Sanofi-Aventis US LLC jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Infectious Disease4Type 2 Diabetes3Cardiology2Oncology2Atrial Fibrillation1
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?